A Multi-Center Phase III Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients aged 50-75 with Intermediate-2 and High Risk Myelodysplastic Syndrome
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.